| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 非甾体抗炎类药物(元) | 81,264,800.16 | 523,743,335.98 | 137,828,950.33 | 128,758,473.76 | 112,748,474.20 |
| 抗过敏类药物(元) | 81,006,961.86 | 186,620,716.73 | 151,238,543.73 | 262,078,331.79 | 177,106,408.10 |
| 消化类药物(元) | - | 58,272,925.91 | 134,525,887.25 | 236,277,736.33 | 109,055,047.68 |
| 心脑血管类药物(元) | - | - | 128,428,690.72 | - | 135,672,045.68 |
| 抗生素类药物(元) | 189,665,006.24 | 212,766,272.55 | 156,625,936.06 | 434,606,939.78 | 167,812,714.43 |
| 急救药(元) | - | 78,890,564.28 | - | 164,016,541.43 | - |
| 皮肤病类药物(元) | - | 66,183,647.28 | - | 69,550,293.91 | - |
| 心血管类药物(元) | - | 119,926,207.82 | - | 330,868,400.85 | - |
| 其他(元) | - | 58,079,670.03 | - | 180,187,868.52 | - |
| 营业成本(元) | |||||
| 非甾体抗炎类药物(元) | 22,889,317.64 | 41,445,357.09 | 24,857,981.72 | - | 10,541,982.34 |
| 抗过敏类药物(元) | 34,796,781.08 | 41,511,516.96 | 29,022,560.97 | 40,086,518.48 | 23,803,101.25 |
| 消化类药物(元) | - | - | 28,841,270.46 | 87,167,525.93 | 25,627,936.21 |
| 心脑血管类药物(元) | - | - | 22,042,692.96 | - | 30,865,390.39 |
| 抗生素类药物(元) | 53,274,787.04 | 132,894,163.91 | 71,539,447.90 | 162,401,297.15 | 52,609,285.97 |
| 急救药(元) | - | - | - | - | - |
| 皮肤病类药物(元) | - | - | - | - | - |
| 心血管类药物(元) | - | - | - | 94,000,445.90 | - |
| 其他(元) | - | - | - | - | - |
| 毛利(元) | |||||
| 非甾体抗炎类药物(元) | 58,375,482.52 | 482,297,978.89 | 112,970,968.61 | - | 102,206,491.86 |
| 抗过敏类药物(元) | 46,210,180.78 | 145,109,199.77 | 122,215,982.76 | 221,991,813.31 | 153,303,306.85 |
| 消化类药物(元) | - | - | 105,684,616.79 | 149,110,210.40 | 83,427,111.47 |
| 心脑血管类药物(元) | - | - | 106,385,997.76 | - | 104,806,655.29 |
| 抗生素类药物(元) | 136,390,219.20 | 79,872,108.64 | 85,086,488.16 | 272,205,642.63 | 115,203,428.46 |
| 急救药(元) | - | - | - | - | - |
| 皮肤病类药物(元) | - | - | - | - | - |
| 心血管类药物(元) | - | - | - | 236,867,954.95 | - |
| 其他(元) | - | - | - | - | - |
| 毛利率(%) | |||||
| 非甾体抗炎类药物(%) | 71.83 | 92.09 | 81.96 | - | 90.65 |
| 抗过敏类药物(%) | 57.04 | 77.76 | 80.81 | 84.70 | 86.56 |
| 消化类药物(%) | - | - | 78.56 | 63.11 | 76.50 |
| 心脑血管类药物(%) | - | - | 82.84 | - | 77.25 |
| 抗生素类药物(%) | 71.91 | 37.54 | 54.32 | 62.63 | 68.65 |
| 急救药(%) | - | - | - | - | - |
| 皮肤病类药物(%) | - | - | - | - | - |
| 心血管类药物(%) | - | - | - | 71.59 | - |
| 其他(%) | - | - | - | - | - |
| 收入构成(%) | |||||
| 非甾体抗炎类药物(%) | 23.09 | 40.15 | 19.45 | 7.13 | 16.05 |
| 抗过敏类药物(%) | 23.02 | 14.31 | 21.34 | 14.51 | 25.21 |
| 消化类药物(%) | - | 4.47 | 18.98 | 13.08 | 15.53 |
| 心脑血管类药物(%) | - | - | 18.12 | - | 19.32 |
| 抗生素类药物(%) | 53.89 | 16.31 | 22.10 | 24.06 | 23.89 |
| 急救药(%) | - | 6.05 | - | 9.08 | - |
| 皮肤病类药物(%) | - | 5.07 | - | 3.85 | - |
| 心血管类药物(%) | - | 9.19 | - | 18.32 | - |
| 其他(%) | - | 4.45 | - | 9.98 | - |
| 毛利构成(%) | |||||
| 非甾体抗炎类药物(%) | 24.22 | 68.19 | 21.22 | 0.00 | 18.29 |
| 抗过敏类药物(%) | 19.18 | 20.52 | 22.96 | 25.22 | 27.43 |
| 消化类药物(%) | - | 0.00 | 19.85 | 16.94 | 14.93 |
| 心脑血管类药物(%) | - | - | 19.98 | - | 18.75 |
| 抗生素类药物(%) | 56.60 | 11.29 | 15.98 | 30.93 | 20.61 |
| 急救药(%) | - | 0.00 | - | 0.00 | - |
| 皮肤病类药物(%) | - | 0.00 | - | 0.00 | - |
| 心血管类药物(%) | - | 0.00 | - | 26.91 | - |
| 其他(%) | - | 0.00 | - | 0.00 | - |